Drawing for ARBITRAGE MEDICAL

USPTO serial 85923866

ARBITRAGE MEDICAL

Reviewed by CopyMark Law Group

Reg. 4685366Status 710
Filing date
Status date
Registration date
Feb 10, 2015
Examiner
ELTON, DAVID JONATHAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ARBITRAGE MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

ARLENE D. HANKS Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003

Goods and services

ClassDescriptionStatusFirst use
044Medical services; medical care and treatment; medical consultation; healthcare; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of stem cell therapies; medical services, namely, stem cell treatment, stem cell transplantation, and stem cell therapy; medical consultancy in relation to stem cell treatment, transplantation and therapy; medical and surgical services using stem cells, stem cell derivatives, and stem cell byproducts; healthcare services in the nature of treating diseases, injuries, or disorders using stem cell therapies and technologies; medical services, namely, treatment of cardiovascular diseases through the use of stem cell therapies and technologies; medical services, namely, the collection, testing, processing, storage and retrieval of blood, blood components, tissue, and stem cells for medical treatment and diagnostics; providing medical and healthcare information; providing medical information in the field of stem cell therapy, stem cell technologies and medical procedures that utilize stem cells; providing on-line medical information for others in the field of stem cells; web-based cardiovascular examination, assessment and analysis services for medical diagnostic and treatment purposesSECTION 8 - CANCELLEDAug 14, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2021C8..CANCELLED SEC. 8 (6-YR)—
Feb 10, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 18, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 10, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 7, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 6, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 16, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 15, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 13, 2014IUAFUSE AMENDMENT FILED—
Nov 13, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 5, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 3, 2014EX1GSOU EXTENSION 1 GRANTED—
Jun 3, 2014EXT1SOU EXTENSION 1 FILED—
Jun 3, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 15, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 10, 2013ALIEASSIGNED TO LIE—
Aug 29, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Aug 29, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 29, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 29, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 23, 2013DOCKASSIGNED TO EXAMINER—
May 13, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance